Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

15-Minute Blood Test Diagnoses Life-Threatening Infections in Children

By LabMedica International staff writers
Posted on 14 Nov 2025

Distinguishing minor childhood illnesses from potentially life-threatening infections such as sepsis or meningitis remains a major challenge in emergency care. More...

Traditional tests can take hours, leaving clinicians to rely on their judgement or prescribe precautionary antibiotics while awaiting results. Now, a new trial is evaluating a rapid 15-minute blood test designed to identify whether an infection is viral or bacterial, enabling faster and more accurate treatment decisions for children.

The trial, which is underway at three hospitals in the UK, including St Mary’s Hospital, Imperial College Healthcare NHS Trust (London, UK), runs until March 2026 and involves testing children who arrive at emergency departments with fever or suspected infection. The new test provides clinicians with crucial diagnostic clarity in just 15 minutes.

By showing whether an infection is bacterial or viral, it offers an important advantage over conventional laboratory testing, which can take several hours to produce results. Faster diagnosis means patients can be treated sooner and antibiotics can be reserved for cases where they are truly needed, reducing the risk of missed serious infections while also preventing unnecessary prescribing.

The trial aims to understand how real-world emergency teams will use this rapid test and whether it improves safety and decision-making. Current practice often forces clinicians to make assumptions while waiting for lab results, sometimes leading to under- or over-treatment. With a quick point-of-care reading, the new test could help avoid delays in identifying children who require urgent intervention.

The potential impact extends beyond individual diagnoses. Fever is one of the most common reasons children visit emergency departments, and many are prescribed antibiotics unnecessarily. A reliable rapid test could reduce avoidable antibiotic use, improve early detection of serious infections, and support efforts to combat antimicrobial resistance.

“This trial will now tell us whether the test has a role in the NHS and if clinicians will use it to help make faster, more accurate decisions so children receive the right treatment faster,” said Dr Ruud Nijman, pediatric consultant at St Mary’s Hospital and honorary clinical senior lecturer at Imperial College London. “If successful, this test has the potential to completely change the way we treat infections and help us diagnose with more certainty, stopping illnesses escalating to something more serious.

Related Links:
St Mary’s Hospital, Imperial College Healthcare NHS Trust


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.